finance.yahoo.comX4 Pharmaceuticals Announces Inducement Grants Under Nasdaq ListingRule 5635(c)(4)about 1 year ago
finance.yahoo.comX4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is a favorite amongst institutional investors who own 51%over 1 year ago
finance.yahoo.comX4 Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updatesover 1 year ago
benzinga.com5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And Moreover 1 year ago
finance.yahoo.comX4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)over 1 year ago
finance.yahoo.comX4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updatesover 1 year ago
finance.yahoo.comX4 Pharmaceuticals to Report First-Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 7, 2024over 1 year ago
benzinga.comFDA Approves X4 Pharmaceuticals' Mavorixafor As First Therapy For Rare Immunodeficiency Disorderover 1 year ago
benzinga.comX4 Pharmaceuticals to Report Fourth-Quarter and Full Year 2023 Financial Results and Host a Conference Call and Webcast on March 21, 2024almost 2 years ago
finance.yahoo.comX4 Pharmaceuticals Announces Inducement Grants Under Nasdaq ListingRule 5635(c)(4)almost 2 years ago